3,4-Dihydro-2H-isoquinoline-1-thione, 95.0%, 250mg

N-(3-Fluorophenyl)pivalamide, 95.0%, 1g

1,4-Dioxane, min 99,5%, pour synthèse, stabilisé, 1L, emballage verre

tert-Butyl 5-bromo-3-chloropicolinate, 95+%, 5g

2-chloro-N-(5-methyl-3-isoxazolyl)acetamide, 95.0%, 250mg

2-(2-Chloropyrimidin-4-yl)-1-(4-fluorophenyl)ethan-1-one, 98%, 250mg

N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(piperazin-1-yl)propoxy)quinazolin-4-amine, 97%, 1g

N-(pyrrolidin-3-yl)methanesulfonamide hydrochloride, 95.0%, 1g

4-Bromo-2,6-difluorotoluene, 98.0%, 100g

2'-Deoxycytidine hydrochloride, 99.0%, 1g

TERT-BUTYL (5-BROMO-4-CYANOTHIAZOL-2-YL)CARBAMATE, 95.0%, 1g

1-(N-(2,2,2-trifluoroethyl)sulfamoyl)piperidine-3-carboxylic acid, 95.0%, 250mg

Octadecylamine Hydrochloride>98.0%(T)25g